News
Eli Lilly Forms Venture To Focus On Xigris Sepsis Drug(LLY) and private investors Care Capital and NovaQuest Capital agreed to jointly create biotechnology company BioCritica Inc. to focus on Lilly's severe sepsis drug Xigris. Sepsis is a severe illness in which the bloodstream is overwhelmed by bacteria. ... read more
New Life Sciences Company to Establish Headquarters in Indiana
The company will license Lilly's FDA-approved drug for the treatment of severe sepsis, adding other products to its portfolio over time. Sepsis is a poisoning of the blood that affects hundreds of thousands of patients each year, many resulting in ... read more
Study Finds Insurance Type is Linked to Sepsis Risk and Survival
COLUMBUS, Ohio – Through an examination of nationwide hospital admissions, researchers have found, regardless of age, adults who are insured by Medicare, Medicaid or both are at a much higher risk of being hospitalized with sepsis, a toxic systemic ... read more
Post a Comment